Page last updated: 2024-08-25

bromopyruvate and Carcinoma, Ovarian Epithelial

bromopyruvate has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuxe, J; Johansson, J; Löfstedt, L; Pedersen, AB; Shoshan, M; Wintzell, M1

Other Studies

1 other study(ies) available for bromopyruvate and Carcinoma, Ovarian Epithelial

ArticleYear
Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate.
    Cancer biology & therapy, 2012, Volume: 13, Issue:14

    Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Ascites; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Humans; Hyaluronan Receptors; Isoenzymes; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Ovarian Neoplasms; Proto-Oncogene Proteins c-kit; Pyruvates; Retinal Dehydrogenase

2012